List of works by Lars Wallentin

2008 National Cardiology Guidelines: Prioritization requires consideration to other factors than scientific studies alone

scientific article published in May 2008

5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study

scientific article published on 01 September 2006

A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score

scientific article published on 21 October 2017

A catalog of genetic loci associated with kidney function from analyses of a million individuals

scientific article published on 31 May 2019

A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: an ASSENT-2 ECG/VCG substudy

scientific article

A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors

scientific article published on 31 August 2017

A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study

scientific article published in December 2002

A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)

scientific article (publication date: August 2002)

A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes

scientific article published in February 2004

ABSTRACTS

scholarly article

ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial

scientific article published on 29 November 2019

Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy

scientific article published in July 2004

Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease

scientific article published on 01 November 1999

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy

scientific article (publication date: February 2004)

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST–elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy11Guest Editor for this manuscript

article by Stefan K James et al published February 2004 in American Heart Journal

Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK.

scientific article

Additional events in the RE-LY trial

scientific article published on 24 September 2014

Additional value of thallium-201 SPECT to a conventional exercise test for the identification of severe coronary lesions after an episode of unstable coronary artery disease

scientific article published on 01 June 1995

Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes

scientific article published on 01 February 2019

Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction

scientific article published on 26 October 2005

Admission Troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction

scientific article published on 01 January 2004

Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey

scientific article published on 7 February 2006

Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: Findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS

scientific article published on 01 October 2006

Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial

scientific article published on 27 April 2016

All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome

scientific article

Ambulatory ST-recording has no additional value to exercise test for identification of severe coronary lesions after an episode of unstable coronary artery disease in men

scientific article published on 01 December 1993

Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial

scientific article published on 01 October 2014

An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease

scientific article (publication date: April 2005)

An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome

scientific article published on 21 February 2017

Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study

scientific article published on 9 March 2004

Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

scientific article published on 22 December 2016

Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial

scientific article published on 30 March 2015

Angina, "normal" coronary angiography, and vascular dysfunction: risk assessment strategies

scientific article

Angiographic Outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes)

article

Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation

scientific article published on 27 September 2020

Antibodies against MYC-Associated Zinc Finger Protein: An Independent Marker in Acute Coronary Syndrome?

scientific article published on 21 November 2017

Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial

scientific article published on 7 January 2015

Anticoagulants in heart disease: current status and perspectives

scientific article published on 10 April 2007

Anticoagulation Therapy in Atrial Fibrillation in Combination With Acute Myocardial Infarction Influences Long-Term Outcome

scientific article published on 01 November 2005

Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial

scientific article published on 7 November 2016

Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?

scientific article

Antithrombotic Therapy Use and Clinical Outcomes Following Thromboembolic Events in Patients with Atrial Fibrillation: Insights from ARISTOTLE.

scientific article published on 29 January 2018

Antithrombotic drug development for atrial fibrillation: proceedings, Washington, DC, July 25-27, 2005.

scientific article published on May 2008

Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention

scientific article published on 6 November 2017

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis.

scientific article published on 2 March 2018

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.

scientific article published on 09 July 2015

Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative

scientific article

Antithrombotics in acute coronary syndromes

scientific article published on September 2009

Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial

scientific article published on 27 July 2016

Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 Trial.

scientific article published in August 2015

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

scientific article published on 8 May 2012

Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial

scientific article published on 24 October 2017

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale

scientific article published in March 2010

Apixaban in patients with atrial fibrillation and prior coronary artery disease: insights from the ARISTOTLE trial

scientific article

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Advanced Chronic Kidney Disease

scientific article published on 12 March 2020

Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

scientific article published on 25 July 2013

Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

scientific article published on 20 October 2013

Apixaban with antiplatelet therapy after acute coronary syndrome

scientific article

Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

scientific article published on 26 May 2009

Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation

scientific article published on 3 November 2016

Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis

scientific article

Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin

scientific article published on 6 February 2009

Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction

scientific article published in The Journal of the American Medical Association

Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction

scientific article published on 12 January 2011

Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction

scientific article published on February 2015

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events

scientific article published on 21 March 2019

Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation

scientific article published on 31 August 2020

Association of Factor V Leiden with Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data

scientific article published on 13 July 2020

Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study

scientific article published on 01 December 2018

Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial).

scientific article published on 25 December 2013

Association of cyclooxygenase-2 genetic variant with cardiovascular disease

scientific article published on 5 May 2014

Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial

scientific article published on 18 January 2012

Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS

scientific article published on 01 September 2004

Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial

scientific article published on 26 September 2014

Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention

article

Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease

scientific article

Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy

scientific article published on 01 August 2018

Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation

scientific article published on 13 June 2013

Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes

scientific article

Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial

scientific article

Benefits of extended treatment with dalteparin in patients with unstable coronary artery disease eligible for revascularization

scientific article (publication date: August 2002)

Biochemical indicators of cardiac and renal function in a healthy elderly population

scientific article published in March 2004

Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease

scientific article published on August 2017

Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome

scientific article

Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial

scientific article

Biomarkers in atrial fibrillation: a clinical review

scientific article published on 05 February 2013

Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibi

scientific article published on 29 October 2013

Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation

scientific article published on 02 February 2016

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction

scientific article published on 27 August 2017

Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial).

scientific article

Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction

scientific article published on 03 October 2018

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

scientific article published on 16 November 2011

Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.

scientific article published in May 2004

Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

scientific article published on December 2015

Blood cell activation, coagulation, and inflammation in men and women with coronary artery disease

scientific article published on 01 August 2001

C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes

scientific article published on 26 September 2019

Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE - LY Trial

Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy

scientific article published on 28 February 2012

Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial

scientific article published on 30 April 2020

CardioScape mapping the cardiovascular funding landscape in Europe.

scientific article published on 25 April 2017

Cardiovascular Medicine in Sweden: Improvement by Continuous Measuring

scientific article published on 06 April 2020

Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment

scientific article published on 01 March 2010

Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease

Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial

scientific article

Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial

scientific article published on 08 May 2020

Cardiovascular risk factors and clinical presentation in acute coronary syndromes

scientific article (publication date: September 2005)

Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study

scientific article

Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes

scientific article published on 23 June 2014

Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals

scientific article published on 25 March 2013

Changes in Renal Function in Patients With Atrial Fibrillation: An Analysis From the RE-LY Trial

scientific article published in June 2015

Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome

scientific article published on 24 June 2015

Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial)

scientific article published on 07 August 2019

Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis

scientific article published on 26 March 2020

Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial

scientific article published on 07 November 2018

Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes

article

Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban--an oral, direct and selective factor Xa inhibitor

scientific article published on 01 August 2011

Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial.

scientific article published on 25 September 2015

Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay

scientific article published on 21 December 2006

Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial

scientific article published on 6 November 2017

Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial

scientific article published on 01 March 2020

Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy

scientific article published in June 2003

Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial

scientific article published on 11 May 2019

Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

scientific article published on 28 September 2014

Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

scientific article published on 16 October 2017

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

scientific article published on 12 December 2014

Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial

scientific article published on 14 September 2015

Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial

scientific article published on 01 April 2015

Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy)

scientific article published on 01 May 2002

Clopidogrel and warfarin: absence of interaction in patients receiving long-term anticoagulant therapy for non-valvular atrial fibrillation

scientific article published on May 1, 2003

Cockcroft-Gault is better than the Modification of Diet in Renal Disease study formula at predicting outcome after a myocardial infarction: data from the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Eval

scientific article

Common variants associated with plasma triglycerides and risk for coronary artery disease

scientific article

Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block

scientific article published on 27 September 2004

Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52,816 Patients from 12 Randomized Trials

scientific article published on 29 May 2020

Comparison between strategies using creatine kinase-MB(mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a nondiagnostic electrocardiogram

scientific article published on 01 December 2000

Comparison of Cardiac Troponins I and T Measured with High-Sensitivity Methods for Evaluation of Prognosis in Atrial Fibrillation: An ARISTOTLE Substudy

Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial).

scientific article published on 28 July 2015

Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy).

scientific article published on 05 August 2016

Comparison of Platelet Reactivity in Black Versus White Patients With Acute Coronary Syndromes After Treatment With Ticagrelor.

scientific article published on 25 January 2017

Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial

scientific article

Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosis.

scientific article

Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial

scientific article published on 28 May 2015

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

scientific article published on 14 March 2006

Comparison of hospital variation in acute myocardial infarction care and outcome between Sweden and United Kingdom: population based cohort study using nationwide clinical registries

scientific article

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

scientific article

Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) tria

scientific article

Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation

scientific article published on 09 July 2018

Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial

scientific article published on 27 December 2012

Consideration of the total ST-segment deviation on the initial electrocardiogram for predicting final acute posterior myocardial infarct size in patients with maximum ST-segment deviation as depression in leads V1 through V3. A FRISC II substudy

scientific article (publication date: July 2005)

Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)

scientific article published on 28 August 2015

Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study

scientific article published on 19 June 2012

Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study.

scientific article published on 29 November 2011

Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet Inhibition and Patient Outcomes (PLATO) study

scientific article

Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome

scientific article

D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy.

scientific article published on 28 January 2016

D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial

scientific article published on 24 July 2014

Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation

scientific article

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

scientific article published on 6 November 2010

Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial

scientific article

Dabigatran etexilate and reduction in serum apolipoprotein B

scientific article published on 09 November 2015

Dabigatran versus warfarin in patients with atrial fibrillation

scientific article

Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation

scientific article published on 06 June 2013

Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial

scientific article published on 07 May 2011

Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study

scientific article published on 17 May 2017

Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).

scientific article published on 17 August 2007

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease

article

Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)

scientific article published in 2022

Daylight saving time shifts and incidence of acute myocardial infarction--Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).

scientific article published on 30 January 2012

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

scientific article published in March 2017

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial

scientific article

Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndrom

scientific article

Development of myocardial microcirculation and metabolism in acute ST-elevation myocardial infarction evaluated with positron emission tomography

scientific article

Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization

scientific article published in February 2004

Diagnostic and prognostic importance of ST recording after an episode of unstable angina or non-Q-wave myocardial infarction ⬇️

scientific article published on 01 February 1992

Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease

scientific article published on 24 April 2016

Differences between acute myocardial infarction and unstable angina: a longitudinal cohort study reporting findings from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA).

scientific article published on 2 January 2013

Different perspectives on outcomes in patients with non-ST-elevation myocardial infarction when observed in clinical trials and in real life

Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome

scientific article

Digoxin and Mortality in Patients With Atrial Fibrillation.

scientific article published in March 2018

Discovery and refinement of loci associated with lipid levels

scientific article

Documentation of study medication dispensing in a prospective large randomized clinical trial: experiences from the ARISTOTLE Trial

Documento de Consenso de Expertos sobre el uso de agentes antiplaquetarios

scientific article published on 01 October 2004

Dynamic vectorcardiography for early diagnosis of acute myocardial infarction compared with 12-lead electrocardiogram. BIOMACS Study Group

scientific article published on 01 December 1996

ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007.

scientific article published on 26 November 2008

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

scientific article

Early angiography in patients with chronic kidney disease: a collaborative systematic review

scientific article published on 07 May 2009

Early assessment of long-term risk with continuous ST-segment monitoring among patients with unstable coronary syndromes. Results from 1-year follow-up in the TRIM study

scientific article published on 01 April 2001

Early assessment of patients with suspected acute myocardial infarction by biochemical monitoring and neural network analysis.

scientific article published in October 1997

Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial

scientific article (publication date: March 2007)

Early diagnosis and exclusion of acute myocardial infarction by two hours' vector-ECG and determination of either myoglobin or CK-mb. BIOMACS-study. BIOchemical Markers in Acute Coronary Syndromes

scientific article published on 01 January 2000

Early exercise testing after coronary care for suspected unstable coronary artery disease--safety and diagnostic value

scientific article published on 01 July 1986

Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease

scientific article published on December 2006

Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study

scientific article

Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis

scientific article published in July 2008

Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study

scientific article published on 01 May 2002

Early statin treatment following acute myocardial infarction and 1-year survival

scientific article published on 01 January 2001

Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin

scientific article

Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial

scientific article published on 29 March 2017

Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study

scientific article published on February 2015

Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction

scientific article published on 11 March 2010

Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect

scientific article published on 18 May 2017

Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial

scientific article

Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

scientific article published on 9 June 2016

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation

scientific article published on 12 September 2018

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

scientific article published on 2 May 2015

Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial

scientific article published on 26 July 2013

Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial

scientific article published on 25 March 2013

Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding events

scientific article

Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-

scientific article

Effects of an early invasive strategy on ischemia and exercise tolerance among patients with unstable coronary artery disease

scientific article

Effects of apixaban compared with warfarin as gain in event-free time - a novel assessment of the results of the ARISTOTLE trial

scientific article published on 07 November 2019

Effects of dabigatran according to age in atrial fibrillation

scientific article published on 17 February 2017

Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment

scientific article

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial

scientific article published on 14 March 2006

Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial

scientific article published on 21 July 2018

Effects of the platelet inhibitor ticlopidine on exercise tolerance in stable angina pectoris

scientific article published on 01 January 1987

Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial

scientific article published on 17 January 2017

Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical Trial

scientific article published on July 2016

Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight

scientific article published on 01 May 2019

Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial.

scientific article published on 21 July 2017

Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

scientific article published on 15 December 2015

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

scientific article

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.

scientific article

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.

scientific article published on 2 May 2013

Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE

scientific article published on 06 June 2014

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial

scientific article published on 09 April 2019

Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study

scientific article published on 01 February 2012

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

scientific article

Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time-A RE-LY trial analysis

scientific article published on 05 January 2018

Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis

scientific article published on 09 December 2013

Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation--sub-analysis in Japanese population in RE-LY trial.

scientific article published on 19 March 2011

Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial

scientific article published on 15 October 2007

Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomi

scientific article published on 7 July 2003

Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3)

Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data

scientific article

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

scientific article published on 29 August 2012

Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction

scientific article (publication date: June 2004)

Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women

scientific article published on 28 June 2007

Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study

scientific article published on 31 May 2018

EuroHeart: European Unified Registries On Heart Care Evaluation and Randomized Trials

scientific article published on 01 September 2019

European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes

scientific article published on 26 August 2020

Evaluating the place of low-molecular-weight heparin in the management of acute coronary syndromes. A panel discussion with audience participation

scientific article published in March 2001

Evaluation of Temporal Changes in Cardiovascular Biomarker Concentrations Improves Risk Prediction in an Elderly Population from the Community

scientific article published on 14 January 2016

Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials

scientific article published on 01 September 2020

Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits

scientific article

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology

scientific article published on January 2004

Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

scientific article

Extracellular vesicles in atrial fibrillation and stroke

scientific article published on 15 July 2020

Factors Contributing to the Lower Mortality With Ticagrelor Compared With Clopidogrel in Patients Undergoing Coronary Artery Bypass Surgery

article

Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trials

scientific article published on 29 November 2018

Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy ⬇️

scientific article published on 29 January 2018

Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohort

scientific article published on 01 April 2003

Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction

scientific article published on 11 January 2006

Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials

scientific article published on 01 February 2019

From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary Syndromes: JACC State-of-the-Art Review

scientific article published on 01 September 2019

From European to national guidelines on heart disease

scientific article published on 06 December 2010

GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men

scientific article (publication date: 2013)

Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

scientific article published on 31 October 2019

Gender differences in management and outcome in non-ST-elevation acute coronary syndrome

scientific article

Gender perspective on risk factors, coronary lesions and long-term outcome in young patients with ST-elevation myocardial infarction

scientific article published in March 2010

General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.

scientific article published on 28 February 2013

Genetic determinants of dabigatran plasma levels and their relation to bleeding

scientific article

Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy

scientific article published on 4 August 2016

Genetic substudy of the PLATO trial – Authors' reply

scientific article published in The Lancet

Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome

scientific article published on 16 June 2006

Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease

scientific article published on 09 May 2009

Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes

scientific article published on 20 October 2005

Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome

scientific article published on 24 November 2015

Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome

scientific article

Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

scientific article published on 16 October 2020

Genomic correlates of glatiramer acetate adverse cardiovascular effects lead to a novel locus mediating coronary risk

scientific article

Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).

scientific article published on 18 February 2015

Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease

scientific article published on 01 October 2008

Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease

scientific article

Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease

scientific article published on 25 October 2016

Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding

scientific article

Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non ST-Elevation Acute Coronary Syndrome

article by K. C. Wollert et al published 2 October 2007 in Circulation

Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARI

scientific article published on 07 October 2014

Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22

scientific article published on 21 October 2010

Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study

scientific article published on 28 September 2015

Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial

scientific article

Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain

scientific article published on 29 July 2008

Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome

scientific article published on 11 December 2009

Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction

scientific article published on 31 October 2007

Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study

scientific article

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

scientific article

Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST

Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy

scientific article

Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trial

scientific article published on 15 May 2013

Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial

scientific article published on 28 December 2020

High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction

scientific article

High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men.

scientific article published on 13 August 2013

High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

scientific article

High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin

scientific article published on 19 September 2013

Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil

scientific article published in August 2011

History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.

scientific article

Hospital therapy traditions influence long-term survival in patients with acute myocardial infarction

scientific article published on 01 January 2005

How can we optimize the processes of care for acute coronary syndromes to improve outcomes?

scientific article

Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-study

scientific article published on 15 January 2020

Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial

article

Impact of an invasive strategy on 5 years outcome in men and women with non-ST-segment elevation acute coronary syndromes

scientific article published on 13 July 2014

Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial

scientific article published on 13 April 2016

Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study

scientific article published on 23 January 2020

Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy

scientific article published on 2 May 2014

Improved adherence to Swedish national guidelines for acute myocardial infarction: the Quality Improvement in Coronary Care (QUICC) study

scientific article published on 01 December 2006

Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission

scientific article (publication date: December 2007)

Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers

scientific article published on 10 January 2006

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.

scientific article published on 29 August 2017

Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes

scientific article

Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers

scientific article

In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events

scientific article published on 18 April 2020

Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome

scientific article published on 28 March 2018

Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A COllaboration between Multiple inst

scientific article published on 06 December 2020

Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

scientific article published on 24 October 2017

Influence of left bundle branch block on long-term mortality in a population with heart failure

scientific article published on 31 July 2007

Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommen

scientific article

Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes

scientific article published on 01 September 2007

Influence on coagulation activity by subcutaneous LMW heparin as an adjuvant treatment to fibrinolysis in acute myocardial infarction

scientific article

Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy

scientific article published on October 2010

Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial

scientific article published on 01 April 2019

Interleukin-18 in patients with acute coronary syndromes

scientific article published on 09 October 2019

Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation

scientific article

International differences in treatment effect: do they really exist and why?

scientific article

Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial

scientific article

Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy

scientific article published on 29 March 2017

Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators

scientific article published on July 2001

Is patient involvement during hospitalization for acute myocardial infarction associated with post-discharge treatment outcome? An exploratory study

scientific article published on 23 June 2010

Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study

scientific article published on 29 January 2018

Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy

scientific article published on May 2016

Large-Scale Exome-wide Association Analysis Identifies Loci for White Blood Cell Traits and Pleiotropy with Immune-Mediated Diseases

scientific article

Large-scale association analysis identifies new risk loci for coronary artery disease

scientific article published on 02 December 2012

Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial

scientific article published on 10 April 2013

Letter by Damman et al regarding articles, "Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual pat

scientific article published in August 2012

Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

scientific article published on 21 June 2016

Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients

scientific article published on 21 February 2007

Long-Term Low-Molecular-Weight Heparin (Fragmin) and/or Early Revascularization During Instability in Coronary Artery Disease (the FRISC II Study) ⬇️

scientific article published on September 4, 1997

Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina: One-Year Survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial

scientific article published on 01 January 2003

Long-term Outcome of Primary Percutaneous Coronary Intervention vs Prehospital and In-Hospital Thrombolysis for Patients With ST-Elevation Myocardial Infarction

scientific article published in The Journal of the American Medical Association

Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA

scientific article

Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation

scientific article published on 03 March 2016

Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data

scientific article

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden

scientific article published on 12 February 2007

Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden

scientific article

Long-term treatment with ximelagatran, an oral direct thrombin inhibitor, persistently reduces the coagulation activity after a myocardial infarction

scientific article (publication date: October 2005)

Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction—the ASSENT Plus study ⬇️

scientific article (publication date: May 2003)

Low-molecular-weight heparin (Fragmin) during instability in coronary artery disease (FRISC). FRISC Study Group

scientific article published in September 1997

Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus

scientific article

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

scientific article

Lowered anti-beta1 adrenergic receptor antibody concentrations may have prognostic significance in acute coronary syndrome

scientific article published on 10 October 2019

Lp-PLA2, scavenger receptor class B type I gene (SCARB1) rs10846744 variant, and cardiovascular disease

scientific article published in PLoS ONE

Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization

scientific article published on June 2015

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

article

Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures

scientific article

Management and outcomes of major bleeding during treatment with dabigatran or warfarin

scientific article published on 30 September 2013

Management strategies for a better outcome in unstable coronary artery disease

scientific article published on May 1998

Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD Council

scientific article

Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy

scientific article published on 01 October 2001

Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).

scientific article published on August 2010

Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.

scientific article published on January 2009

Meta-Analysis of Intraocular Bleeding With Dual Antiplatelet Therapy Using P2Y12 Inhibitors Prasugrel or Ticagrelor

scientific article published on 29 January 2020

Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes

scientific article

Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline

scientific article published on 30 October 2020

Methodology for the development of international clinical data standards for common cardiovascular conditions: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)

scientific article published in 2021

Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease

scientific article published in February 2004

Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial

scientific article published on 3 January 2012

N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).

scientific article published on 3 April 2013

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arte

scientific article published on 7 July 2003

N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease

scientific article published on December 2003

NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes: Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO).

scientific article published on 6 March 2015

NT-ProBNP in non-ST-elevation acute coronary syndrome

scientific article

NT-proBNP in unstable coronary artery disease--experiences from the FAST, GUSTO IV and FRISC II trials

scientific article

Natriuretic peptide should be used as a routine tool for evaluation of patients with atrial fibrillation

scientific article published on 12 October 2018

Natriuretic peptides in unstable coronary artery disease

scientific article published in September 2004

New generation cardiac troponin I assay for the access immunoassay system

scientific article published on 01 May 2001

New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis

scientific article

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper

scientific article

Newly identified events in the RE-LY trial

scientific article published on 01 November 2010

Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics

scientific article published on 04 July 2020

Niemann-Pick C1 modulates hepatic triglyceride metabolism and its genetic variation contributes to serum triglyceride levels

scientific article published on 20 May 2010

No Significant Relationship Between Ticagrelor and Sleep Apnea in Large, Randomized, Blinded Trials

scientific article published on 01 April 2020

No misrepresentation of vital status follow-up in PLATO: predefined analyses guarantee the integrity of the benefits of ticagrelor over clopidogrel in the PLATO trial: Commentary on: DiNicolantonio JJ, Tomek A, Misrepresentation of vital status foll

scientific article

No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial

scientific article published on August 2007

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation

scientific article

Noninvasive risk stratification in unstable coronary artery disease: exercise test and biochemical markers. FRISC Study Group

scientific article published on September 1997

Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial

article published in 2018

Observer variability and optimal criteria of transient ischemia during ST monitoring with continuous 12-lead ECG

scientific article published on 01 July 2002

Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study

scientific article

Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease

scientific article published on 8 March 2016

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

scientific article (publication date: 6 September 2003)

Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial

scientific article published on 12 January 2018

Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients—Results from the PLATelet inhibition and patient Outcomes (PLATO) study

scientific article published on 17 October 2012

Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease

scientific article

Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial

scientific article published in October 2004

Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab

scientific article published in October 2003

Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial b

scientific article published on 4 April 2016

Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease

scientific article published on 19 January 2018

Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry

scientific article published on 19 July 2016

Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial

scientific article published on 22 November 2018

Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial

scientific article published on 17 April 2013

Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease

scientific article published on 9 December 2005

P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use.

scientific article published on 24 July 2009

PROTEIN-CODING VARIANTS IMPLICATE NOVEL GENES RELATED TO LIPID HOMEOSTASIS CONTRIBUTING TO BODY FAT DISTRIBUTION

article

Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease

scientific article published on 28 March 2013

Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome

scientific article published on 22 July 2008

Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial

scientific article published on 21 November 2019

Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes

scientific article published on 4 July 2006

Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo

scientific article

Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial

scientific article published on 24 April 2019

Percutaneous Coronary Intervention vs Thrombolysis for ST-Elevation Myocardial Infarction—Reply

scientific article published in The Journal of the American Medical Association

Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial

scientific article published on 10 November 2017

Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation

scientific article published on 28 August 2016

Periodontal disease in patients with chronic coronary heart disease: Prevalence and association with cardiovascular risk factors

scientific article published on 10 April 2014

Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.

scientific article published on 4 December 2014

Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial

scientific article published on 14 June 2012

Persistence of the prothrombotic state after acute coronary syndromes: implications for treatment

scientific article (publication date: February 2002)

Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality

scientific article published on 01 October 2007

Persistent inhibition of platelet function during long-term treatment with 75 mg acetylsalicylic acid daily in men with unstable coronary artery disease

scientific article published on 01 March 1991

Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors ⬇️

scientific article

Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib

scientific article published on 28 July 2017

Physical Activity and Mortality in Patients With Stable Coronary Heart Disease

scientific article

Physical activity in patients with stable coronary heart disease: an international perspective

scientific article published on 06 September 2013

Plasma fibrinogen in unstable coronary artery disease

scientific article published on 01 February 1989

Platelet-Related Variants Identified by Exomechip Meta-analysis in 157,293 Individuals

scientific article

Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome.

scientific article published on 12 June 2017

Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study

article

Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial

scientific article published on 15 June 2016

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial

scientific article published on 01 November 2011

Population pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in aspirin-treated patients with stable coronary artery disease

scientific article published on 21 November 2008

Possible reasons for the prognostic value of troponin-T on admission in patients with ST-elevation myocardial infarction

scientific article published on 01 May 2001

Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI

scientific article published on 01 July 2020

Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials

scientific article published on March 2017

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

scientific article published on 30 November 2007

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

scientific article (publication date: May 2006)

Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile

scientific article

Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction

scientific article published on 19 April 2006

Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy

scientific article published on 07 May 2020

Prehospital diagnosis and start of treatment reduces time delay and mortality in real-life patients with STEMI.

scientific article

Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation

scientific article published on 16 September 2020

Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

scientific article published on 01 November 2019

Prevention of cardiovascular events after acute coronary syndrome

scientific article (publication date: August 2005)

Prevention of serious cardiac events by low-dose aspirin in patients with silent myocardial ischaemia. The Research Group on Instability in Coronary Artery Disease in Southeast Sweden

scientific article published on August 29, 1992

Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

article

Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice

scientific article published in April 2004

Prognostic Value of Ischemia Monitoring with On-Line Vectorcardiography in Patients with Unstable Coronary Artery Disease

scholarly article by Peter Lundin et al published 2000 in Cardiology

Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.

scientific article

Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel

scientific article published on 23 December 2019

Prognostic importance of early exercise testing in men with suspected unstable coronary artery disease

scientific article published on 01 August 1987

Prognostic relevance of PCI-related myocardial infarction.

scientific article published on 26 February 2013

Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study).

scientific article

Prognostic value of ST-segment resolution-when and what to measure

scientific article published on February 2003

Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome

scientific article

Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome

scientific article published on 5 February 2007

Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

scientific article published on 22 December 2017

Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution

article

ProteinSeq: high-performance proteomic analyses by proximity ligation and next generation sequencing

scientific article (publication date: 2011)

Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease

scientific article

Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity

scientific article published on 01 July 2019

Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.

scientific article published on 16 March 2018

Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.

scientific article

Pulmonary Function in Patients With Acute Coronary Syndrome Treated With Ticagrelor or Clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] Pulmonary Function Substudy)

article

Quantitative ST-depression in acute coronary syndromes: the PLATO electrocardiographic substudy

scientific article published on 21 June 2013

Quantitative T-wave analysis predicts 1 year prognosis and benefit from early invasive treatment in the FRISC II study population

scientific article published on 30 November 2004

Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment

scientific article

Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome

scientific article (publication date: June 2008)

Rapid Endovascular Catheter Core Cooling Combined With Cold Saline as an Adjunct to Percutaneous Coronary Intervention for the Treatment of Acute Myocardial Infarction

scientific article published on 05 February 2014

Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran

scientific article published in May 2009

Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.

scientific article published on 31 December 2012

Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER.

scientific article

Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial

scientific article published on 30 December 2019

Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register

scientific article

Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group

scientific article published on 01 May 1996

Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014

scientific article published on 01 November 2018

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

scientific article published on 26 May 2017

Relations of growth-differentiation factor-15 to biomarkers reflecting vascular pathologies in a population-based sample of elderly subjects

scientific article published on 24 October 2011

Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

scientific article published on February 2016

Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes

scientific article published on 12 October 2009

Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-a case-control study

scientific article published on 20 July 2011

Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy

scientific article published in November 2001

Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trial

scientific article published on 9 June 2017

Renal Function in Atrial Fibrillation: A Multifaceted Dilemma

scientific article published in July 2016

Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time

scientific article

Reply to Letters Regarding Article, “Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Tria

Reply: Anticoagulant-Related Nephropathy

scientific article published on 01 December 2015

Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed

scientific article published on 01 July 2018

Reply: Higher N-terminal Pro-B-type natriuretic peptide may be related to very different conditions

scientific article published on 24 July 2013

Reply: regarding the effect of dabigatran plasma concentrations

scientific article published on 07 May 2014

Response to letter regarding article, "Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy".

scientific article

Response to letter regarding article, "Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study"

scientific article published on 01 August 2014

Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".

scientific article

Response to letter regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial a

scientific article published on 01 November 2014

Response to letter regarding article, "Management and outcomes of major bleeding during treatment with dabigatran or warfarin"

scientific article published on 01 September 2014

Response to letter regarding article, "Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial".

scientific article

Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials".

scientific article published on 25 June 2013

Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”.

scientific article published in March 2013

Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudication

scientific article

Risk Markers of Incident Atrial Fibrillation in Patients with Coronary Heart Disease

scientific article published on 02 January 2021

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

scientific article published on 16 May 2011

Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group

scientific article published on 01 May 1997

Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial

scientific article published in November 2011

Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials

scientific article published on June 2005

ST Elevation Acute Coronary Syndromes in PLATO

article

ST resolution 1 hour after fibrinolysis for prediction of myocardial infarct size: insights from ASSENT 3.

scientific article

ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction

scientific article published in August 2003

ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy

scientific article published on 16 December 2011

ST-segment analyses and residual thrombi in the infarct-related artery: a report from the ASSENT PLUS ST-monitoring substudy

scientific article

ST-segment monitoring with continuous 12-lead ECG improves early risk stratification in patients with chest pain and ECG nondiagnostic of acute myocardial infarction

scientific article published on 01 November 1999

ST2 and mortality in non-ST-segment elevation acute coronary syndrome

scientific article

Safety and efficacy of abciximab combined with dalteparin in treatment of acute coronary syndromes

scientific article (publication date: October 2002)

Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention

scientific article published on 4 February 2016

Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis

scientific article published on 07 May 2018

Safety profile and tolerability of intravenous AR-C69931MX, a new antiplatelet drug, in unstable angina pectoris and non-Q-wave myocardial infarction

scientific article (publication date: May 2002)

Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation

scientific article published on 09 December 2020

Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study

scientific article published on 10 April 2012

Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

scientific article

Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy

scientific article published in February 2005

Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials

scientific article published on 08 June 2020

Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

scientific article published on 14 September 2017

Sex, age, and clinical presentation of acute coronary syndromes

scientific article published on 01 April 2004

Sharing Data from Cardiovascular Clinical Trials--A Proposal

scientific article

Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation

scientific article

Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers

scientific article published on September 2006

Should the exercise test (ET) be performed at discharge or one month later after an episode of unstable angina or non-Q-wave myocardial infarction? ⬇️

scientific article published on January 1, 1991

Similar outcome with an invasive strategy in men and women with non-ST-elevation acute coronary syndromes: from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapi

scientific article published on 11 September 2011

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

scientific article published in The Lancet

Smoking in relation to ST-segment elevation acute myocardial infarction: findings from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions

scientific article published in June 2009

Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome

scientific article published on 20 April 2006

Stent Thrombosis With Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes

article

Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial

scientific article published on 01 December 2018

Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease

scientific article published on 02 January 2021

Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

scientific article published on October 2010

Subsequent Event Risk in Individuals With Established Coronary Heart Disease

scientific article published on 21 March 2019

Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome

scientific article published on April 2016

Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry

scientific article published on 01 February 2020

The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial.

scientific article

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

scientific article published on 25 February 2016

The ABC risk score for patients with atrial fibrillation - Authors' reply.

scientific article

The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice

scientific article

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study

scientific article published on 14 June 2013

The PLATO trial reveals further opportunities to improve outcomes in patients with acute coronary syndrome. Editorial on Serebruany. "Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified" (Thromb Haemost 2011;

scientific article published on 11 March 2011

The SCAAR-scare in perspective.

scientific article published in September 2009

The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART).

scientific article published on 27 August 2010

The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease

scientific article published on 01 April 1999

The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).

scientific article

The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial

scientific article

The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electroca

scientific article published in May 2011

The low-molecular-weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: the ASSENT PLUS study

scientific article (publication date: March 2001)

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.

scientific article

The predictive value of silent ischemia at an exercise test before discharge after an episode of unstable coronary artery disease ⬇️

scientific article published on 01 February 1992

The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy

scientific article published in May 2002

The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial

scientific article

The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004

scientific article published on 14 August 2006

Therapeutic hypothermia for the treatment of acute myocardial infarction-combined analysis of the RAPID MI-ICE and the CHILL-MI trials

scientific article

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

scientific article

Thrombolysis with recombinant human tissue-type plasminogen activator during instability in coronary artery disease: effect on myocardial ischemia and need for coronary revascularization. TRIC Study Group

scientific article published on 01 December 1992

Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes

scientific article published on 01 September 2012

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery

article

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial

scientific article published on 9 October 2015

Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial

scientific article published on 27 June 2011

Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial

scientific article published on 19 February 2014

Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials

scientific article published on 9 April 2013

Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

scientific article published on 18 April 2019

Ticagrelor treatment in patients with acute coronary syndrome is cost-effective in Sweden and Denmark

scientific article published on 17 April 2014

Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial

scientific article published on 31 March 2015

Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial

scientific article published on 30 August 2010

Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis

scientific article

Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial

scientific article

Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial

scientific article

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial

scientific article

Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial

scientific article published on 17 March 2005

Time-based measures of treatment effect: reassessment of ticagrelor and clopidogrel from the PLATO trial

scientific article

Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Insta

scientific article

Tooth loss is independently associated with poor outcomes in stable coronary heart disease

scientific article published on 16 December 2015

Towards a new order in cardiovascular medicine: re-engineering through global collaboration

article

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

scientific article published in March 2017

Treatment with an oral direct thrombin inhibitor decreases platelet activity but increases markers of inflammation in patients with myocardial infarction

scientific article published on 23 February 2011

Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial

scientific article published on August 2003

Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction

scientific article (publication date: 27 June 2002)

Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy

scientific article published on March 2003

Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy

scientific article published on 28 August 2006

Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction

scientific article (publication date: May 2003)

Understanding the use of observational and randomized data in cardiovascular medicine

scientific article published on 04 February 2020

Unraveling the spectrum of left bundle branch block in acute myocardial infarction: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT 2 and 3) trials

scientific article

Unreliable Observations from a Confounded Analysis of a Skewed Database

Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial

scientific article

Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation

scientific article published on 01 October 2018

Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial

scientific article

Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).

scientific article published on 18 June 2014

Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).

scientific article published on 21 November 2005

Usefulness of the admission electrocardiogram to predict long-term outcomes after non-ST-elevation acute coronary syndrome (from the FRISC II, ICTUS, and RITA-3 [FIR] Trials).

scientific article published on 23 September 2011

Utilisation of novel anti-platelet agents: evidence, guidelines and proven patients’ value

article

Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial

scientific article

Variants of the Interferon Regulatory Factor 5 Gene Regulate Expression of IRF5 mRNA in Atherosclerotic Tissue But Are Not Associated With Myocardial Infarction

article

Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulati

scientific article published on October 2012

Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry.

scientific article published on 24 January 2014

Variations in pre-hospital fibrinolysis process of care: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic 3 Plus international acute myocardial infarction pre-hospital care survey

scientific article published on June 2004

Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial

scientific article

Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease

scientific article published on 14 November 2013

Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).

scientific article published on 21 November 2013

Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial

scientific article published on 16 September 2014

Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial.

scientific article published on 13 March 2014

Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes

scientific article published in February 2010

Why don't we return to bare metal stents?

scientific article published on May 2008

Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA).

scientific article published in May 2008

[Care of myocardial infarction strongly improved 1995-2005. Quality registry, open statements and clear therapeutic goals have payed off]

scientific article published on 01 May 2007

[Emergency coronary care--successful, but unequaly distributed]

scientific article published on 01 June 1998

[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]

scientific article published on 01 December 2004

[Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes].

scientific article

[Policy document. Catheter-based diagnosis and treatment of coronary diseases]

scientific article published on 01 January 2001

[Riks-HIA will develop a new index for areas with room for improvement]

scientific article published on 01 March 2012

[Swedish work with national guidelines can become an international model. With perspectives from cardiovascular diseases guidelines]

scientific article published on 01 April 2008

[Use of percutaneous coronary vessel interventions should be increased. 400 interventions per year is a minimum capacity of decentralized services]

scientific article published on 01 November 1999

Paulina is supported by:

About Paulina

Help